Similarly, the evaluation of the percentage of myeloid-derived suppressor cells (MDSC) indicated a significantly higher percentage of these cells expressing PD-L1 in PAH patients, compared to controls. This evidence concerns the gene CD274 and pulmonary arterial hypertension.